Syngene International has signed Research and Development (R&D) agreement with GSK, a science-led global healthcare company. The multiyear agreement will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services platforms.
As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas. A team of Syngene scientists will work closely with GSK’s global R&D teams on discovery research projects to identify new drug candidates with the potential to address some of the world’s most pressing healthcare needs.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
Company Name | CMP |
---|---|
Syngene Internation. | 683.25 |
Sagility India | 42.29 |
AGS Transact Tech | 11.46 |
Just Dial | 837.00 |
Krystal Integrated | 428.70 |
View more.. |